These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 7957562

  • 1. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM.
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
    Butler DM, Feldmann M, Di Padova F, Brennan FM.
    Eur Cytokine Netw; 1994 Nov; 5(5):441-8. PubMed ID: 7880974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
    Williams LM, Gibbons DL, Gearing A, Maini RN, Feldmann M, Brennan FM.
    J Clin Invest; 1996 Jun 15; 97(12):2833-41. PubMed ID: 8675695
    [Abstract] [Full Text] [Related]

  • 7. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M, Parry SL, Brennan FM, Feldmann M.
    Eur J Immunol; 1997 Mar 15; 27(3):624-32. PubMed ID: 9079801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B.
    Pol Merkur Lekarski; 2003 Jan 15; 14(79):69-72. PubMed ID: 12712835
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K, Yamamura M, Iwahashi M, Otsuka F, Yamana J, Sunahori K, Kawashima M, Yamada M, Makino H.
    Arthritis Res Ther; 2006 Jan 15; 8(4):R126. PubMed ID: 16859503
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM, Bodman-Smith MD, Brunst M, Cornell H, Panayi GS.
    Arthritis Rheum; 2004 Apr 15; 50(4):1164-71. PubMed ID: 15077298
    [Abstract] [Full Text] [Related]

  • 14. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
    Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP.
    J Immunol; 1998 Apr 01; 160(7):3513-21. PubMed ID: 9531313
    [Abstract] [Full Text] [Related]

  • 15. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S, Morand V, Millet S, Bruneau JM, Bhatnagar N, Chouaib S, Roman-Roman S.
    Cytokine; 1997 May 01; 9(5):340-6. PubMed ID: 9195133
    [Abstract] [Full Text] [Related]

  • 16. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH, Choi JH, Byun MS, Jue DM.
    Rheumatology (Oxford); 2006 Jun 01; 45(6):703-10. PubMed ID: 16418198
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT, Han YB, Park JM, Kennedy M, Planck SR.
    J Rheumatol; 1998 Dec 01; 25(12):2408-16. PubMed ID: 9858438
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA, Kipps TJ.
    Cell Immunol; 1995 Apr 01; 161(2):226-35. PubMed ID: 7535196
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts.
    Alaaeddine N, Di Battista JA, Pelletier JP, Kiansa K, Cloutier JM, Martel-Pelletier J.
    Cytokine; 1999 Dec 01; 11(12):1020-30. PubMed ID: 10623427
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB, Saget BM, Wang MZ, Wang A, Dinarello CA, Skolnik PR.
    J Interferon Cytokine Res; 1995 Jun 01; 15(6):575-84. PubMed ID: 7553227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.